ARCC’s new Partnership with Current Oncology

We are excited to announce a new partnership with Current Oncology whereby ARCC members will receive author fee discounts when publishing in this important jounal. Please email karen.irwin@mdpi.com for more details.

Current Oncology (ISSN 1718-7729) is an international, peer-reviewed, open access journal published online by MDPI (from Volume 28 Issue 1-2021). Established in 1994, the journal represents a multidisciplinary medium for clinical oncologists to report and review progress in the management of this disease. 

The journal is supported by Editor in Chief Dr. Shahid Ahmed, from the University of Saskatchewan, and an international editorial board consisting of a distinguished team of cancer researchers from major institutes from Canada and around the world (http://www.mdpi.com/journal/curroncol/editors). Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine. 

Current Oncology is indexed by important databases, including SCIE, PubMed, MEDLINE, Scopus. Current Oncology received an IF score of 2.6, rising to 176/241 in the ‘Oncology’ category rankings with a 5 year Impact Factor of 2.9 in 2022. More information about the journal can be accessed at: http://www.mdpi.com/journal/curroncol.

ARCC members enjoy author fee discounts with our affiliated journal, Current Oncology. Email Karen for more info at karen.irwin@mdpi.com.

NOTE:  When you apply for research funding, please inquire whether your granting agency allows the costs of open access publishing, such as Article Processing Charges, to be included in the grant budget. More and more, granting agencies are encouraging or even requiring that all papers resulting from funded research must be published in Open Access journals.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply